Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan;14(1):36-43.
doi: 10.1016/j.jsxm.2016.11.318.

Role of Nanotechnology in Erectile Dysfunction Treatment

Alice Y Wang  1 , Carol A Podlasek  2
Affiliations
Review

Role of Nanotechnology in Erectile Dysfunction Treatment

Alice Y Wang et al. J Sex Med. 2017 Jan.

Abstract

Introduction: The biological importance of nanotechnology-based delivery vehicles for in vivo tissue regeneration is gaining acceptance by the medical community; however, its relevance and incorporation into the treatment of sexual dysfunction are evolving and have not been well evaluated.

Aim: To provide scientific evidence examining the use of state-of-the-art nanotechnology-based delivery methodology in the treatment of erectile dysfunction (ED) in animal models and in patients.

Methods: This review assessed the current basic science literature examining the role of nanotechnology-based delivery vehicles in the development of potential ED therapies.

Results: There are four primary areas where nanotechnology has been applied for ED treatment: (i) topical delivery of drugs for on-demand erectile function, (ii) injectable gels into the penis to prevent morphologic changes after prostatectomy, (iii) hydrogels to promote cavernous nerve regeneration or neuroprotection, and (iv) encapsulation of drugs to increase erectile function (primarily of phosphodiesterase type 5 inhibitors).

Conclusion: Basic science studies provide evidence for a significant and evolving role for nanotechnology in the development of therapies for ED and suggest that properly administered nano-based therapies might be advantageous for treating male sexual dysfunction.

Keywords: Cavernous Nerve; Erectile Dysfunction; Hydrogel; Nanotechnology; Penis.

PubMed Disclaimer

Conflict of interest statement

None

References

    1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54–61. - PubMed
    1. Heruti R, Shochat T, Tekes-Manova D, Ashkenazi I, Justo D. Prevalence of erectile dysfunction among young adults: results of a large-scale survey. J Sex Med. 2004;1:284–291. - PubMed
    1. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, Rodriguez-Vela L, Jimenez Cruz JF, Burgos-Rodriguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfunction Erectil Masculina study. J Urol. 2001;166:569–574. - PubMed
    1. Han G, Tar M, Dwaraka SR, Kuppam MA, Friedman A, Melman A, Friedman J, Davies KP. Nanoparticles as a novel delivery vehicle for therapeutics targeting erectile dysfunction. J Sex Med. 2010;7:224–233. - PMC - PubMed
    1. Tar M, Cabrales P, Mahantesh N, Adler B, Nacharaju P, Friedman A, Friedman J, Davies KP. Topically applied NO-releasing nanoparticles can increase intracorporal pressure and elicit spontaneous erections in a rat model of radical prostatectomy. J Sex Med. 2014;11:2903–2914. - PMC - PubMed

Substances